Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-16-000323
Filing Date
2016-08-15
Accepted
2016-08-15 17:22:17
Documents
2
Period of Report
2016-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5812
2 EDGAR SUPPORTING DOCUMENT poaberns.txt EX-24 3648
  Complete submission text file 0001232524-16-000323.txt   10948
Mailing Address 11080 CIRCLEPOINT RD., STE, 200 WESTMINSTER CO 80020
Business Address
BERNS PAUL L (Reporting) CIK: 0001202769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 161834008

Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations